XM does not provide services to residents of the United States of America.
X
X

Xylem

News

US crude, gasoline inventories likely rose last week, distillates seen down

RPT-POLL-US crude, gasoline inventories likely rose last week, distillates seen down Repeats Tuesday's poll with no changes Nov 19 (Reuters) - U.S. crude oil and gasoline stockpiles likely rose last week, while distillate inventories were seen down, an extended Reuters poll showed on Tuesday. Nine analysts polled by Reuters estimated on average that crude inventories rose by about 100,000 barrels in the week to Nov.
X

US crude, gasoline inventories likely rose last week, distillates seen down

POLL-US crude, gasoline inventories likely rose last week, distillates seen down Nov 19 (Reuters) - U.S. crude oil and gasoline stockpiles likely rose last week, while distillate inventories were seen down, an extended Reuters poll showed on Tuesday. Nine analysts polled by Reuters estimated on average that crude inventories rose by about 100,000 barrels in the week to Nov.
X

U.S. Apollo, Booking Holdings, Portillos

U.S. RESEARCH ROUNDUP-Apollo, Booking Holdings, Portillos Nov 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apollo, Booking Holdings and Portillos, on Wednesday. HIGHLIGHTS * Apollo APO.N : JP Morgan raises target price to $161 from $143 * Aris Water Solutions Inc ARIS.N : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Truist Securities raises target to $4,700 from $4,100 * Choice Hotel
A
E
M
C
F
X
B
C
C
E
G
L

Xylem Inc reports results for the quarter ended in September 30 - Earnings Summary

Xylem Inc reports results for the quarter ended in September 30 - Earnings Summary Xylem Inc XYL.N reported quarterly adjusted earnings of $1.11​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 99 cents. The mean expectation of seventeen analysts for the quarter was for earnings of $1.11 per share.
X

Xylem trims annual revenue forecast after key product sales miss estimates

Xylem trims annual revenue forecast after key product sales miss estimates Oct 31 (Reuters) - Xylem XYL.N trimmed its annual revenue forecast after reporting lower-than-expected sales for some of its key equipment used for water treatment, dragging the company's shares nearly 5% lower in premarket trade. The water technology firm now expects revenue of $8.50 billion for 2024, compared with a previous forecast of about $8.55 billion.
X

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.